Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment

Condition:   Graft Versus Host Disease in Eye Interventions:   Drug: Cyclosporine;   Drug: tacrolimus Sponsor:   Peking University Third Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials